Influence of fluvastatin on MMP-2, TGF-β_1 and left ventricular remodeling in rats with heart failure
Dai Ha
Abstract
Dai Ha
Abstract
AIM: To investigate the influence of fluv-astation on matrix metalloproteinase-2 ( MMP-2) and transforming growth factor beta-1 (TCF-β1) in the development of left ventricular remodeling and heart failure of rats after myocardial infarction (MI) and the mechanisms of left ventricular remodeling and heart failure after myocardial infarction. METHODS: 67 male Sprague-Dawley (SD) rats were randomly divided into three groups: the sham group, the MI group and the MI + statin group. The MI model was induced by ligating the left anterior descending coronary artery. After 24 hours of ligation, animals in the MI + statin group were treated with fluvastatin (4 mg·kg-1·d-1 ), and animals in the sham group and the MI group were treated with placebo. Rats were sacrificed 3 days, 4 weeks and 8 weeks after treatment. The content of MMP-2 protein (by Western-blot) and the expression of TGF-β1 were determined, and the collagen volume fraction (CVF) and the ratio of type Ⅰ to Ⅲ collagen (by immunohistochemistry) in the noninfarcted zone were assessed. Left ventricular function was measured atdifferent times. RESULTS: The levels of MMP-2 and TGF-β1 in the noninfarcted zone were significantly higher in the MI group and the MI + statin group than that in the sham group ( P 0.05) , but it was significantly lower in the MI + statin group than that in the MI group ( P 0.05) 3 days, 4 weeks and 8 weeks after treatment. Compared with the MI group, left ventricular function of rats in the MI + statin group was significantly improved. CVF and type Ⅰ /Ⅲ collagen ratio in the MI + statin group were significantly lower than that in the MI group ( P 0.05) 4 weeks and 8 weeks after treatment. CONCLUSION: Fluvastatin can relieve the destruction of the collagen network and deposition of redundant reactive collagen in cardiac muscles through decreasing the MMP-2 and TGF-β1, of cardiac muscle in the noninfarcted zone. Fluvastatin can prevent and reverse the left ventricular remodeling and improve the cardiac function.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To investigate the influence of fluv-astation on matrix metalloproteinase-2 ( MMP-2) and transforming growth factor beta-1 (TCF-β1) in the development of left ventricular remodeling and heart failure of rats after myocardial infarction (MI) and the mechanisms of left ventricular remodeling and heart failure after myocardial infarction. METHODS: 67 male Sprague-Dawley (SD) rats were randomly divided into three groups: the sham group, the MI group and the MI + statin group. The MI model was induced by ligating the left anterior descending coronary artery. After 24 hours of ligation, animals in the MI + statin group were treated with fluvastatin (4 mg·kg-1·d-1 ), and animals in the sham group and the MI group were treated with placebo. Rats were sacrificed 3 days, 4 weeks and 8 weeks after treatment. The content of MMP-2 protein (by Western-blot) and the expression of TGF-β1 were determined, and the collagen volume fraction (CVF) and the ratio of type Ⅰ to Ⅲ collagen (by immunohistochemistry) in the noninfarcted zone were assessed. Left ventricular function was measured atdifferent times. RESULTS: The levels of MMP-2 and TGF-β1 in the noninfarcted zone were significantly higher in the MI group and the MI + statin group than that in the sham group ( P 0.05) , but it was significantly lower in the MI + statin group than that in the MI group ( P 0.05) 3 days, 4 weeks and 8 weeks after treatment. Compared with the MI group, left ventricular function of rats in the MI + statin group was significantly improved. CVF and type Ⅰ /Ⅲ collagen ratio in the MI + statin group were significantly lower than that in the MI group ( P 0.05) 4 weeks and 8 weeks after treatment. CONCLUSION: Fluvastatin can relieve the destruction of the collagen network and deposition of redundant reactive collagen in cardiac muscles through decreasing the MMP-2 and TGF-β1, of cardiac muscle in the noninfarcted zone. Fluvastatin can prevent and reverse the left ventricular remodeling and improve the cardiac function.
Key concepts: Ventricular remodeling, Fluvastatin, Medicine, Internal medicine, Myocardial infarction, Cardiology, Heart failure, Statin